SCHEMBL16410751

SCHEMBL16410751

N=Cc1ccccc1CNNC1=Nc2ccccc2NC12CCN(N)CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410634 0.82 CXCR4 (0.34) —
SCHEMBL16410538 0.79 KMT2A (0.32) —
SCHEMBL16410613 0.77 — —
SCHEMBL16410633 0.77 ACAT2 (0.37) —
SCHEMBL16410697 0.75 — —
SCHEMBL16410601 0.75 — —
SCHEMBL16410786 0.75 — —
SCHEMBL16410824 0.73 PDE7A (0.38) —
SCHEMBL16410747 0.73 PDE7A (0.38) —
SCHEMBL16410604 0.72 ACAT2 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback